Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Respiratory Syncytial Virus
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection
- Status
- TERMINATED
- Phase
- PHASE2
A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive
- Status
- COMPLETED
- Phase
- PHASE1
Pre-Approval Access to JNJ-53718678 for the Treatment of Respiratory Syncytial Virus (RSV) Infection in (a) Immunocompromised Adult and Pediatric Participants
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy of MEDI7510 in Older Adults
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants
- Status
- COMPLETED
- Phase
- PHASE1
Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections
- Status
- COMPLETED
- Phase
- N/A
A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Infections
- Status
- COMPLETED
- Phase
- N/A
A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age
- Status
- COMPLETED
- Phase
- NA
Cough Assist in Bronchiolitis
- Status
- TERMINATED
- Phase
- NA
Sofia RSV FIA Field Study
- Status
- COMPLETED
- Phase
- N/A
MEDI-557 Adult Dosing
- Status
- COMPLETED
- Phase
- PHASE1